Purchase this article with an account.
Moritz Niemeyer, Oliver Klaproth, Thomas Kohnen; AcrySof Cachet Phakic IOL in Myopic Eyes- First year results. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1382.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
First year results after implantation of angle supported phakic AcrySof Cachet IOL to correct moderate to high myopia.
This retrospective study enrolled 72 myopic eyes in which the phakic AcrySof Cachet IOL were implanted by the same surgeon (T.K.). Pre- and postoperative the endothelium cell loss, intraocular eye pressure and visual acuity (BCVA) were compared.
The mean MSRE reduced significantly from -9.06 D + 2.51 to -0.15 + 0.42 at one month and to -0.12 + 0.36 after the first year (p<0.05). Only two percent of the patients lost one line of visual acuity, 44% gained one and 11% two lines. The aimed correction of + 0.5 D MSRE was reached by 84% of the patients (100% within +1.0 D). The mean percentage of endothelial cell loss was 2.3% after one year. Intraocular eye pressure showed no significantly difference from preoperatively to one year after surgery.
The angle supported AcrySof Cachet IOL is an efficient and safe device to correct moderate to high myopia. It provids excellent visual performance and stable endothelial cell counts.
This PDF is available to Subscribers Only